{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T01:50:00Z","timestamp":1767664200323,"version":"3.48.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025KY1314"],"award-info":[{"award-number":["2025KY1314"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LY23H080003"],"award-info":[{"award-number":["LY23H080003"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81971991"],"award-info":[{"award-number":["81971991"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Discipline Cluster of Oncology of Wenzhou Medical University of China","award":["z2-2023021"],"award-info":[{"award-number":["z2-2023021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy with poor overall survival (OS). Resistance to chemotherapeutic drugs such as idarubicin (IDA) remains a major cause of treatment failure. This study investigated the anti-leukemic activity of halofuginone (HF) a synthetic derivative of the natural compound from hydrangea Dichroa febrifuge and its potential to overcome IDA resistance in AML cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Apoptosis, proliferation, cell cycle, and colony formation were assessed in AML cells treated with HF. RNA sequencing (RNA-seq) was performed to identify the potential molecular targets of HF. The anti-leukemic efficacy of HF was further assessed in NOD\/SCID-IL2R\u03b3 (NSG) mice xenografted with human relapsed\/refractory (R\/R) AML samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      HF treatment significantly inhibited cell proliferation, reduced colony formation, and induced apoptosis in AML cells. By RNA-seq analysis, S100A8 and S100A9 (S100A8\/A9) were identified as potential targets of HF, and HF treatment markedly suppressed their expression. Overexpression of S100A8\/A9 abrogated the anti-leukemic effects of HF, indicating that S100A8\/A9 are critical mediators of HF activity. Mechanistically, HF activated the amino acid starvation response (AAR), leading to phosphorylation of eukaryotic translation initiation factor 2 subunit alpha (p-eIF2\u03b1), subsequent downregulation of S100A8\/A9, and elevation of cytoplasmic Ca\n                      <jats:sup>2<\/jats:sup>\n                      \u207a levels. Knockdown of eIF2\u03b1 prevented HF-induced downregulation of S100A8\/A9, confirming that HF regulates S100A8\/A9 expression via the eIF2\u03b1 pathway. Furthermore, HF treatment inhibited global protein synthesis, enhanced the cytotoxicity of chemotherapeutic drugs, and reversed IDA resistance by suppressing S100A8\/A9 expression. Finally, HF inhibits leukemic infiltration and extended OS in MLL-AF9-transduced AML mice and enhanced IDA-induced anti-leukemic effects in R\/R AML-xenografted NSG mice model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These findings reveal that HF exerts anti-leukemic effects by modulating the p-eIF2\u03b1\u2013S100A8\/A9\u2013Ca\n                      <jats:sup>2<\/jats:sup>\n                      \u207a signaling axis in AML cells. HF represents a promising therapeutic candidate for AML, particularly for patients with IDA-resistant disease.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-025-01278-9","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T01:01:41Z","timestamp":1767661301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Halofuginone exerts broad-spectrum cytotoxic effects by regulating p-eIF2\u03b1-S100A8\/A9-calcium signaling, inhibiting global protein synthesis, and reversing the resistance of idarubicin in acute myeloid leukemia"],"prefix":"10.1186","volume":"21","author":[{"given":"Liuzhi","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongyun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenmeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"12","key":"1278_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H Dohner","year":"2022","unstructured":"Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377.","journal-title":"Blood"},{"issue":"12","key":"1278_CR2","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.3324\/haematol.2018.198614","volume":"103","author":"L Ades","year":"2018","unstructured":"Ades L, Thomas X, Bresler AG, Raffoux E, Spertini O, Vey N, et al. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group. Haematologica. 2018;103(12):2033\u20139.","journal-title":"Haematologica"},{"issue":"11","key":"1278_CR3","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/stem.3263","volume":"38","author":"T Matsukawa","year":"2020","unstructured":"Matsukawa T, Aplan PD. Clinical and molecular consequences of fusion genes in myeloid malignancies. Stem Cells. 2020;38(11):1366\u201374.","journal-title":"Stem Cells"},{"issue":"7104","key":"1278_CR4","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature04980","volume":"442","author":"AV Krivtsov","year":"2006","unstructured":"Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature. 2006;442(7104):818\u201322.","journal-title":"Nature"},{"issue":"2","key":"1278_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000534897","volume":"147","author":"S Buchrits","year":"2024","unstructured":"Buchrits S, Wolach O. Non-immunotherapy approaches for relapsed or refractory AML: an update for 2024. Acta Haematol. 2024;147(2):159\u201374.","journal-title":"Acta Haematol"},{"issue":"6","key":"1278_CR6","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3382\/ps.0581469","volume":"58","author":"SA Edgar","year":"1979","unstructured":"Edgar SA, Flanagan C. Efficacy of Stenorol (halofuginone). I. Against recent field isolates of six species of chicken coccidia. Poult Sci. 1979;58(6):1469\u201375.","journal-title":"Poult Sci"},{"issue":"10","key":"1278_CR7","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1002\/jcb.24185","volume":"113","author":"CJ Deselm","year":"2012","unstructured":"Deselm CJ, Zou W, Teitelbaum SL. Halofuginone prevents estrogen-deficient osteoporosis in mice. J Cell Biochem. 2012;113(10):3086\u201392.","journal-title":"J Cell Biochem"},{"issue":"3","key":"1278_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2174\/157340609788185846","volume":"5","author":"BS Samant","year":"2009","unstructured":"Samant BS, Sukhthankar MG. Synthesis and comparison of antimalarial activity of febrifugine derivatives including halofuginone. Med Chem. 2009;5(3):293\u2013300.","journal-title":"Med Chem"},{"issue":"3","key":"1278_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nchembio.790","volume":"8","author":"TL Keller","year":"2012","unstructured":"Keller TL, Zocco D, Sundrud MS, Hendrick M, Edenius M, Yum J, et al. Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase. Nat Chem Biol. 2012;8(3):311\u20137.","journal-title":"Nat Chem Biol"},{"issue":"5932","key":"1278_CR10","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1126\/science.1172638","volume":"324","author":"MS Sundrud","year":"2009","unstructured":"Sundrud MS, Koralov SB, Feuerer M, Calado DP, Kozhaya AE, Rhule-Smith A, et al. Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response. Science. 2009;324(5932):1334\u20138.","journal-title":"Science"},{"issue":"1","key":"1278_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-015-0181-2","volume":"34","author":"PA Assis","year":"2015","unstructured":"Assis PA, De Figueiredo-Pontes LL, Lima AS, Leao V, Candido LA, Pintao CT, et al. Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model. J Exp Clin Cancer Res. 2015;34(1):65.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1278_CR12","doi-asserted-by":"publisher","first-page":"e1591","DOI":"10.1038\/cddis.2014.554","volume":"6","author":"K Rajesh","year":"2015","unstructured":"Rajesh K, Krishnamoorthy J, Kazimierczak U, Tenkerian C, Papadakis AI, Wang S, et al. Phosphorylation of the translation initiation factor eIF2\u03b1 at serine 51 determines the cell fate decisions of Akt in response to oxidative stress. Cell Death Dis. 2015;6(1):e1591. https:\/\/doi.org\/10.1038\/cddis.2014.554.","journal-title":"Cell Death Dis"},{"issue":"7","key":"1278_CR13","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.bbagrm.2014.12.007","volume":"1849","author":"AE Koromilas","year":"2015","unstructured":"Koromilas AE. Roles of the translation initiation factor eIF2alpha serine 51 phosphorylation in cancer formation and treatment. Biochim Biophys Acta. 2015;1849(7):871\u201380.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1278_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41408-023-00787-w","volume":"13","author":"K Kurata","year":"2023","unstructured":"Kurata K, James-Bott A, Tye MA, Yamamoto L, Samur MK, Tai YT, et al. Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood Cancer J. 2023;13(1):12.","journal-title":"Blood Cancer J"},{"issue":"3","key":"1278_CR15","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.3390\/ijms13032893","volume":"13","author":"T Vogl","year":"2012","unstructured":"Vogl T, Gharibyan AL, Morozova-Roche LA. Pro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexes. Int J Mol Sci. 2012;13(3):2893\u2013917.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1278_CR16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jmb.2006.04.009","volume":"359","author":"N Leukert","year":"2006","unstructured":"Leukert N, Vogl T, Strupat K, Reichelt R, Sorg C, Roth J. Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity. J Mol Biol. 2006;359(4):961\u201372.","journal-title":"J Mol Biol"},{"key":"1278_CR17","doi-asserted-by":"publisher","first-page":"1110185","DOI":"10.3389\/fimmu.2023.1110185","volume":"14","author":"A Moller","year":"2023","unstructured":"Moller A, Jauch-Speer SL, Gandhi S, Vogl T, Roth J, Fehler O. The roles of toll-like receptor 4, CD33, CD68, CD69, or CD147\/EMMPRIN for monocyte activation by the DAMP S100A8\/S100A9. Front Immunol. 2023;14:1110185.","journal-title":"Front Immunol"},{"issue":"3","key":"1278_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/cei.12139","volume":"173","author":"X Xu","year":"2013","unstructured":"Xu X, Chen H, Zhu X, Ma Y, Liu Q, Xue Y, et al. S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1\/2, mitogen-activated protein-kinase and nuclear factor-\u03baB-dependent pathways. Clin Exp Immunol. 2013;173(3):523\u201335. https:\/\/doi.org\/10.1111\/cei.12139.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"1278_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/leu.2010.251","volume":"25","author":"E Nicolas","year":"2011","unstructured":"Nicolas E, Ramus C, Berthier S, Arlotto M, Bouamrani A, Lefebvre C, et al. Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients. Leukemia. 2011;25(1):57\u201365.","journal-title":"Leukemia"},{"issue":"11","key":"1278_CR20","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1182\/bloodadvances.2022008958","volume":"7","author":"YH Wang","year":"2023","unstructured":"Wang YH, Lin CC, Yao CY, Amaral FMR, Yu SC, Kao CJ, et al. High BM plasma S100A8\/A9 is associated with a perturbed microenvironmentand poor prognosis in myelodysplastic syndromes. Blood Adv. 2023;7(11):2528\u201333.","journal-title":"Blood Adv"},{"issue":"21","key":"1278_CR21","doi-asserted-by":"publisher","first-page":"5685","DOI":"10.1182\/bloodadvances.2021005938","volume":"6","author":"M Bottcher","year":"2022","unstructured":"Bottcher M, Panagiotidis K, Bruns H, Stumpf M, Volkl S, Geyh S, et al. Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8\/A9high AML cell subset. Blood Adv. 2022;6(21):5685\u201397.","journal-title":"Blood Adv"},{"issue":"6","key":"1278_CR22","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/leu.2011.388","volume":"26","author":"JA Spijkers-Hagelstein","year":"2012","unstructured":"Spijkers-Hagelstein JA, Schneider P, Hulleman E, de Boer J, Williams O, Pieters R, et al. Elevated S100A8\/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. Leukemia. 2012;26(6):1255\u201365.","journal-title":"Leukemia"},{"issue":"23","key":"1278_CR23","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1182\/bloodadvances.2021005614","volume":"5","author":"ME Zavorka Thomas","year":"2021","unstructured":"Zavorka Thomas ME, Jeon JY, Talebi Z, Buelow DR, Silvaroli J, Campbell MJ, et al. Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia. Blood Adv. 2021;5(23):5041\u20136.","journal-title":"Blood Adv"},{"issue":"20","key":"1278_CR24","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1182\/bloodadvances.2025016061","volume":"9","author":"A Uriepero-Palma","year":"2025","unstructured":"Uriepero-Palma A, Marquez MED, Payque E, Mediavilla-Varela M, Gamal W, Maharaj K, et al. Targeting S100A9-mediated inflammation: a novel therapeutic approach for CLL. Blood Adv. 2025;9(20):5219\u201333.","journal-title":"Blood Adv"},{"issue":"4","key":"1278_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nbt.3807","volume":"35","author":"R Pelossof","year":"2017","unstructured":"Pelossof R, Fairchild L, Huang CH, Widmer C, Sreedharan VT, Sinha N, et al. Prediction of potent shRNAs with a sequential classification algorithm. Nat Biotechnol. 2017;35(4):350\u20133.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1278_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40164-024-00489-4","volume":"13","author":"S Feng","year":"2024","unstructured":"Feng S, Yuan Y, Lin Z, Li M, Ye D, Shi L, et al. Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia. Exp Hematol Oncol. 2024;13(1):19.","journal-title":"Exp Hematol Oncol"},{"issue":"5","key":"1278_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s002800100367","volume":"48","author":"KP Stecklair","year":"2001","unstructured":"Stecklair KP, Hamburger DR, Egorin MJ, Parise RA, Covey JM, Eiseman JL. Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD2F1 mice and Fischer 344 rats. Cancer Chemother Pharmacol. 2001;48(5):375\u201382.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"17","key":"1278_CR28","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1182\/blood-2015-04-639062","volume":"126","author":"Z Li","year":"2015","unstructured":"Li Z, Chen P, Su R, Li Y, Hu C, Wang Y, et al. Overexpression and knockout of miR-126 both promote leukemogenesis. Blood. 2015;126(17):2005\u201315.","journal-title":"Blood"},{"issue":"14","key":"1278_CR29","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1182\/blood-2016-09-738005","volume":"129","author":"M Laouedj","year":"2017","unstructured":"Laouedj M, Tardif MR, Gil L, Raquil MA, Lachhab A, Pelletier M, et al. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4. Blood. 2017;129(14):1980\u201390.","journal-title":"Blood"},{"issue":"1","key":"1278_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41408-023-00962-z","volume":"13","author":"R Fan","year":"2023","unstructured":"Fan R, Satilmis H, Vandewalle N, Verheye E, De Bruyne E, Menu E, et al. Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in acute myeloid leukemia. Blood Cancer J. 2023;13(1):188.","journal-title":"Blood Cancer J"},{"issue":"1","key":"1278_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12964-019-0354-2","volume":"17","author":"C Follo","year":"2019","unstructured":"Follo C, Vidoni C, Morani F, Ferraresi A, Seca C, Isidoro C. Amino acid response by Halofuginone in Cancer cells triggers autophagy through proteasome degradation of mTOR. Cell Commun Signal. 2019;17(1):39.","journal-title":"Cell Commun Signal"},{"issue":"W1","key":"1278_CR32","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gkab418","volume":"49","author":"C Li","year":"2021","unstructured":"Li C, Tang Z, Zhang W, Ye Z, Liu F. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 2021;49(W1):W242\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"6697","key":"1278_CR33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1126\/science.adh7950","volume":"384","author":"NJ Boon","year":"2024","unstructured":"Boon NJ, Oliveira RA, Korner PR, Kochavi A, Mertens S, Malka Y, et al. DNA damage induces p53-independent apoptosis through ribosome stalling. Science. 2024;384(6697):785\u201392.","journal-title":"Science"},{"issue":"6","key":"1278_CR34","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41556-024-01420-z","volume":"26","author":"L Yang","year":"2024","unstructured":"Yang L, Zhang Z, Jiang P, Kong D, Yu Z, Shi D, et al. Phase separation-competent FBL promotes early pre-rRNA processing and translation in acute myeloid leukaemia. Nat Cell Biol. 2024;26(6):946\u201361.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"1278_CR35","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1038\/s41467-024-47848-7","volume":"15","author":"HH Chang","year":"2024","unstructured":"Chang HH, Huang LC, Browning KS, Huq E, Cheng MC. The phosphorylation of carboxyl-terminal eIF2alpha by SPA kinases contributes to enhanced translation efficiency during photomorphogenesis. Nat Commun. 2024;15(1):3467.","journal-title":"Nat Commun"},{"issue":"18","key":"1278_CR36","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1002\/1873-3468.13214","volume":"592","author":"JK Uppala","year":"2018","unstructured":"Uppala JK, Ghosh C, Sathe L, Dey M. Phosphorylation of translation initiation factor eIF2alpha at Ser51 depends on site- and context-specific information. FEBS Lett. 2018;592(18):3116\u201325.","journal-title":"FEBS Lett"},{"key":"1278_CR37","first-page":"482905","volume":"2012","author":"B Ozpolat","year":"2012","unstructured":"Ozpolat B, Akar U, Tekedereli I, Alpay SN, Barria M, Gezgen B, et al. PKCdelta regulates translation initiation through PKR and eIF2alpha in response to retinoic acid in acute myeloid leukemia cells. Leuk Res Treat. 2012;2012:482905.","journal-title":"Leuk Res Treat"},{"issue":"3","key":"1278_CR38","doi-asserted-by":"publisher","first-page":"188891","DOI":"10.1016\/j.bbcan.2023.188891","volume":"1878","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ouyang Y, Li Z, Wang X, Ma J. S100A8 and S100A9 in cancer. Biochim Biophys Acta Rev Cancer. 2023;1878(3):188891. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188891.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"1278_CR39","doi-asserted-by":"publisher","first-page":"6473","DOI":"10.1038\/s41467-023-42257-8","volume":"14","author":"K Qin","year":"2023","unstructured":"Qin K, Yu S, Liu Y, Guo R, Guo S, Fei J, et al. USP36 stabilizes nucleolar Snail1 to promote ribosome biogenesis and cancer cell survival upon ribotoxic stress. Nat Commun. 2023;14(1):6473.","journal-title":"Nat Commun"},{"issue":"19","key":"1278_CR40","doi-asserted-by":"publisher","first-page":"10648","DOI":"10.1093\/nar\/gkaa757","volume":"48","author":"AC Vind","year":"2020","unstructured":"Vind AC, Genzor AV, Bekker-Jensen S. Ribosomal stress-surveillance: three pathways is a magic number. Nucleic Acids Res. 2020;48(19):10648\u201361.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"1278_CR41","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.stem.2022.06.004","volume":"29","author":"C Li","year":"2022","unstructured":"Li C, Wu B, Li Y, Chen J, Ye Z, Tian X, et al. Amino acid catabolism regulates hematopoietic stem cell proteostasis via a GCN2-eIF2alpha axis. Cell Stem Cell. 2022;29(7):1119\u201334.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"1278_CR42","doi-asserted-by":"publisher","first-page":"2196482","DOI":"10.1080\/16078454.2023.2196482","volume":"28","author":"MZ Mohamed Jiffry","year":"2023","unstructured":"Mohamed Jiffry MZ, Kloss R, Ahmed-Khan M, Carmona-Pires F, Okam N, Weeraddana P, et al. A review of treatment options employed in relapsed\/refractory AML. Hematology. 2023;28(1):2196482.","journal-title":"Hematology"},{"issue":"4","key":"1278_CR43","doi-asserted-by":"publisher","first-page":"102952","DOI":"10.1016\/j.jbc.2023.102952","volume":"299","author":"M Polakowska","year":"2023","unstructured":"Polakowska M, Steczkiewicz K, Szczepanowski RH, Wyslouch-Cieszynska A. Toward an understanding of the conformational plasticity of S100A8 and S100A9 Ca(2+)-binding proteins. J Biol Chem. 2023;299(4):102952.","journal-title":"J Biol Chem"},{"issue":"5","key":"1278_CR44","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/bph.15998","volume":"180","author":"B Bai","year":"2023","unstructured":"Bai B, Xu Y, Chen H. Pathogenic roles of neutrophil-derived alarmins (S100A8\/A9) in heart failure: from molecular mechanisms to therapeutic insights. Br J Pharmacol. 2023;180(5):573\u201388.","journal-title":"Br J Pharmacol"},{"key":"1278_CR45","doi-asserted-by":"publisher","first-page":"109733","DOI":"10.1016\/j.cellsig.2020.109733","volume":"75","author":"S Xu","year":"2020","unstructured":"Xu S, Cheng X, Wu L, Zheng J, Wang X, Wu J, et al. Capsaicin induces mitochondrial dysfunction and apoptosis in anaplastic thyroid carcinoma cells via TRPV1-mediated mitochondrial calcium overload. Cell Signal. 2020;75:109733.","journal-title":"Cell Signal"},{"key":"1278_CR46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.freeradbiomed.2023.02.001","volume":"198","author":"JD Pandya","year":"2023","unstructured":"Pandya JD, Musyaju S, Modi HR, Cao Y, Flerlage WJ, Huynh L, et al. Comprehensive evaluation of mitochondrial redox profile, calcium dynamics, membrane integrity and apoptosis markers in a preclinical model of severe penetrating traumatic brain injury. Free Radic Biol Med. 2023;198:44\u201358.","journal-title":"Free Radic Biol Med"},{"issue":"6008","key":"1278_CR47","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1126\/science.1189157","volume":"330","author":"C Giorgi","year":"2010","unstructured":"Giorgi C, Ito K, Lin HK, Santangelo C, Wieckowski MR, Lebiedzinska M, et al. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science. 2010;330(6008):1247\u201351.","journal-title":"Science"},{"issue":"2","key":"1278_CR48","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1039\/C5TX00463B","volume":"5","author":"JY Zhang","year":"2016","unstructured":"Zhang JY, Sun GB, Wang M, Liao P, Du YY, Yang K, et al. Arsenic trioxide triggered calcium homeostasis imbalance and induced endoplasmic reticulum stress-mediated apoptosis in adult rat ventricular myocytes. Toxicol Res. 2016;5(2):682\u20138. https:\/\/doi.org\/10.1039\/C5TX00463B.","journal-title":"Toxicol Res"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01278-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01278-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01278-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T01:01:44Z","timestamp":1767661304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-025-01278-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1278"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01278-9","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our studies were approved by the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University(WYYY-AEC-2023\u2013017) and written informed consent was obtained from all patients according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}